#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fms-like tyrosine kinase 3 positive Epstein-Barr virus associated lymphoproliferative disorder Alveolar proteinosis Bronchopulmonary dysplasia Albright's disease B precursor type acute leukaemia Small for dates baby Hypoparathyroidism Indolent systemic mastocytosis Paraganglion neoplasm Alveolar rhabdomyosarcoma C3 glomerulopathy Cardiac amyloidosis Penile squamous cell carcinoma Transient ischaemic attack More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome – Treatment Kearns-Sayre syndrome Vascular malformation Netherton’s syndrome – Treatment Hereditary angioedema Pulmonary sarcoidosis – Treatment X-linked lymphoproliferative syndrome – Treatment Sjogren’s syndrome Aicardi-Goutieres syndrome – Diagnostics Angiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Entinostat Mavorixafor Gsk4381562A Ibutamoren Mesilate Bay 3018250 Parsaclisib Hydrochloride Sodium Phosphate Dodecahydrate Macrogol 4000 Luspatercept Zinc Oxide SODIUM IBANDRONATE Crn04894 Salbutamol Bi 3720931 OSIMERTINIB MESYLATE POTASSIUM CLAVULANATE Desogestrel Petosemtamab Nystatin HUMAN PLASMA More therapies…

    Learn about Your Condition

    Emphysema Corticobasal degeneration Stomatitis Varices oesophageal Coeliac disease Urinary incontinence Postoperative delirium Myotonic dystrophy Ovarian cancer stage III Procedural pain Cataract Immune system disorder Partial seizures Hepatobiliary cancer Colorectal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Atrial fibrillation

  • Study on Rivaroxaban for Patients with Atrial Fibrillation and Coronary Artery Disease After Heart Procedure

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    • Coronary artery disease
    Investigated Drugs:
    • Rivaroxaban
    The Netherlands

  • Study on Semaglutide for Achieving Sinus Rhythm in Patients with Obesity and Persistent Atrial Fibrillation

    Not recruiting

    3 1
    Investigated Diseases:
    • Palpitations
    • Atrial fibrillation
    • Obesity
    Investigated Drugs:
    • Semaglutide
    The Netherlands

  • Study on Dabigatran, Apixaban, Rivaroxaban, and Edoxaban for Patients with Atrial Fibrillation, Deep Vein Thrombosis, or Pulmonary Embolism

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Deep vein thrombosis
    • Pulmonary embolism
    • Atrial fibrillation
    Investigated Drugs:
    • Dabigatran Etexilate
    • Apixaban
    • Edoxaban
    Denmark

  • Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Milvexian
    • Andexanet Alfa
    • Apixaban
    Belgium Bulgaria Croatia Czechia Denmark Estonia +13

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Asundexian
    • Apixaban
    Austria Belgium Bulgaria Czechia Denmark Estonia +16
Previous Page
1 … 7 8 9

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!